Newsroom

PARIS--(BUSINESS WIRE)--Regulatory News: Advicenne (Euronext Growth Paris - FR0013296746 - ALDVI), a pharmaceutical company specializing in the development and marketing of innovative treatments for people suffering from rare kidney diseases, announces that the FDA (Food and Drug Administration) has accepted for review the New Drug Application (NDA) for Sibnayal® (ADV7103), a fixed combination of potassium citrate and potassium bicarbonate for the treatment of distal Renal Tubular Acidosis (dRT...

PARIS--(BUSINESS WIRE)--Regulatory News: Advicenne (Euronext Growth Paris ALDVI - FR0013296746), société pharmaceutique spécialisée dans le développement et la commercialisation de traitements innovants pour les personnes souffrant de maladies rénales rares, annonce que la FDA (Food and Drug Administration) a accepté la soumission de la demande d’autorisation de mise sur le marché (NDA) aux Etats-Unis pour Sibnayal® (ADV7103, combinaison fixe de citrate et de bicarbonate de potassium) destinée...

東京--(BUSINESS WIRE)--（ビジネスワイヤ） -- 3D Investment Partners Pte. Ltd.（以下「3D」又は「当社」）は、2026年1月16日付で、東邦ホールディングス株式会社（証券コード: 8129、以下「東邦HD」）が導入した買収防衛策の手続に従い、同社に対し、同社株式の取得等に係る「大規模買付行為等説明書」（以下「説明書」）および「ガバナンス体制の整備に関する具体的提言」を提出いたしました。 また、当社は、本日、株主の皆様への透明性の高い情報開示を行うべく上記各書面を公開するとともに、今回の株式取得の意図や背景についてより深くご理解いただくための補足資料として、「当社による東邦HD株式の追加取得に関するご説明資料」（以下「本プレゼン資料」）を公開いたしました。 説明書およびガバナンス体制の整備に関する具体的提言へのリンク[1]: https://www.3dipartners.com/engagement/toho-documentation-jp-202601.pdf 本プレゼン資料へのリンク: https://www.3dipart...

BORDEAUX, France--(BUSINESS WIRE)--Regulatory News: Mon courtier énergie group (ISIN code: FR001400H3A0 – Ticker: ALMCE), a leading energy brokerage group for businesses, today announces its 2025 revenue : Hugo LARRICQ, Chief Executive Officer of Mon courtier énergie group, stated: “The growing share of renewed contracts in our revenue makes our growth both robust and highly predictable. The strong acceleration of our international operations confirms our long-term development potential, while...

BORDEAUX, France--(BUSINESS WIRE)--Mon courtier énergie groupe affiche en 2025 un chiffre d’affaires de 28 M€ (+14%), dont 24,9 M€ en France (+10%) et 1,3 M€ à l’international (+196%)....

PALO ALTO, Calif.--(BUSINESS WIRE)--Uniphore announced a strategic relationship with KPMG LLP to build AI agents & small language models for governed Business AI in regulated industries....

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: Median Technologies (FR0011049824, ALMDT, éligible PEA/PME, « Median » ou « La Société »), fabricant d’eyonis®, une suite de logiciels dispositifs médicaux basés sur l’intelligence artificielle (IA) pour le diagnostic précoce des cancers, et un leader mondial de la fourniture d’analyses d’images par IA et de services centraux d’imagerie pour les essais cliniques en oncologie de l’industrie biopharmaceutique, publie ce jour ses principa...

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, “Median” or the “Company”), manufacturer of eyonis®, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer diagnosis, and a globally leading provider of AI-based image analyses and central imaging services for oncology drug developers, releases today its 2025 key business results (including unaudited figures) and provides a...

FARNBOROUGH, England--(BUSINESS WIRE)--Oshkosh Defense, LLC, an Oshkosh Corporation [NYSE: OSK] business, will showcase its Joint Light Tactical Vehicle (JLTV) platform at the International Armoured Vehicles (IAV) Conference, January 20-22, 2026, in Booth D8. The company will highlight how the combat-proven JLTV adapts to evolving operational demands and modernization requirements across allied forces. With over 24,000 vehicles produced for the U.S. Armed Forces and coalition partners worldwide...

PARIS & NEW YORK--(BUSINESS WIRE)--The ICC and Carbon Measures today announced the first cohort of experts selected to serve on the Technical Expert Panel on Carbon Accounting....